Chloe Douglas-Crampton
Keine laufenden Positionen mehr
Health Technology
Karriereverlauf von Chloe Douglas-Crampton
Ehemalige bekannte Positionen von Chloe Douglas-Crampton
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRILLIUM THERAPEUTICS | Public Communications Contact | 01.11.2004 | - |
| Unternehmenssekretär | 19.10.2009 | - |
Statistik
International
| Kanada | 2 |
Operativ
| Public Communications Contact | 1 |
| Corporate Secretary | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Börse
- Insiders
- Chloe Douglas-Crampton
- Erfahrung
